Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

Prevalence of germ-line mutations in cancer genes among pancreatic cancer patients with a positive family history.

Chaffee KG, Oberg AL, McWilliams RR, Majithia N, Allen BA, Kidd J, Singh N, Hartman AR, Wenstrup RJ, Petersen GM.

Genet Med. 2018 Jan;20(1):119-127. doi: 10.1038/gim.2017.85. Epub 2017 Jul 20.

2.

Angiolymphatic invasion as a prognostic fator in resected N0 pancreatic adenocarcinoma.

Almeida RVS, Pacheco AM Jr, Silva RA, Moricz A, Campos T.

Arq Bras Cir Dig. 2017 Jan-Mar;30(1):42-46. doi: 10.1590/0102-6720201700010012. English, Portuguese.

3.

Familial pancreatic cancer: Concept, management and issues.

Matsubayashi H, Takaori K, Morizane C, Maguchi H, Mizuma M, Takahashi H, Wada K, Hosoi H, Yachida S, Suzuki M, Usui R, Furukawa T, Furuse J, Sato T, Ueno M, Kiyozumi Y, Hijioka S, Mizuno N, Terashima T, Mizumoto M, Kodama Y, Torishima M, Kawaguchi T, Ashida R, Kitano M, Hanada K, Furukawa M, Kawabe K, Majima Y, Shimosegawa T.

World J Gastroenterol. 2017 Feb 14;23(6):935-948. doi: 10.3748/wjg.v23.i6.935. Review.

4.

Pancreatic cancer risk in relation to sex, lifestyle factors, and pre-diagnostic anthropometry in the Malmö Diet and Cancer Study.

Andersson G, Wennersten C, Borgquist S, Jirström K.

Biol Sex Differ. 2016 Dec 9;7:66. eCollection 2016.

5.

Familial pancreatic cancer.

Petersen GM.

Semin Oncol. 2016 Oct;43(5):548-553. doi: 10.1053/j.seminoncol.2016.09.002. Epub 2016 Sep 22. Review.

6.

Association of Common Susceptibility Variants of Pancreatic Cancer in Higher-Risk Patients: A PACGENE Study.

Childs EJ, Chaffee KG, Gallinger S, Syngal S, Schwartz AG, Cote ML, Bondy ML, Hruban RH, Chanock SJ, Hoover RN, Fuchs CS, Rider DN, Amundadottir LT, Stolzenberg-Solomon R, Wolpin BM, Risch HA, Goggins MG, Petersen GM, Klein AP.

Cancer Epidemiol Biomarkers Prev. 2016 Jul;25(7):1185-91. doi: 10.1158/1055-9965.EPI-15-1217. Epub 2016 May 16.

7.

Metformin Use and Survival of Patients With Pancreatic Cancer: A Cautionary Lesson.

Chaiteerakij R, Petersen GM, Bamlet WR, Chaffee KG, Zhen DB, Burch PA, Leof ER, Roberts LR, Oberg AL.

J Clin Oncol. 2016 Jun 1;34(16):1898-904. doi: 10.1200/JCO.2015.63.3511. Epub 2016 Apr 11.

8.

Racial disparities of pancreatic cancer in Georgia: a county-wide comparison of incidence and mortality across the state, 2000-2011.

Brotherton L, Welton M, Robb SW.

Cancer Med. 2016 Jan;5(1):100-10. doi: 10.1002/cam4.552. Epub 2015 Nov 21.

9.

Preferences Regarding Return of Genomic Results to Relatives of Research Participants, Including after Participant Death: Empirical Results from a Cancer Biobank.

Breitkopf CR, Petersen GM, Wolf SM, Chaffee KG, Robinson ME, Gordon DR, Lindor NM, Koenig BA.

J Law Med Ethics. 2015 Fall;43(3):464-75. doi: 10.1111/jlme.12289.

10.

Familial Pancreatic Adenocarcinoma.

Petersen GM.

Hematol Oncol Clin North Am. 2015 Aug;29(4):641-53. doi: 10.1016/j.hoc.2015.04.007. Epub 2015 Jun 9. Review.

11.

A histomorphologic comparison of familial and sporadic pancreatic cancers.

Singhi AD, Ishida H, Ali SZ, Goggins M, Canto M, Wolfgang C, Meriden Z, Roberts N, Klein AP, Hruban RH.

Pancreatology. 2015 Jul-Aug;15(4):387-391. doi: 10.1016/j.pan.2015.04.003. Epub 2015 Apr 23.

12.

Establishing a clinic-based pancreatic cancer and periampullary tumour research registry in Quebec.

Smith AL, Bascuñana C, Hall A, Salman A, Andrei AZ, Volenik A, Rothenmund H, Ferland D, Lamoussenery D, Kamath AS, Amre R, Caglar D, Gao ZH, Haegert DG, Kanber Y, Michel RP, Omeroglu-Altinel G, Asselah J, Bouganim N, Kavan P, Arena G, Barkun J, Chaudhury P, Gallinger S, Foulkes WD, Omeroglu A, Metrakos P, Zogopoulos G.

Curr Oncol. 2015 Apr;22(2):113-21. doi: 10.3747/co.22.2300.

13.

Receptivity and Preferences in Cancer Risk Reduction Lifestyle Programs: A Survey of Colorectal Cancer Family Members.

Howell LA, Brockman TA, Sinicrope PS, Patten CA, Decker PA, Ehlers SL, Lindor NM, Nigon SK, Petersen GM.

J Behav Health. 2013;2(4):279-290.

14.

Familial pancreatic cancer: the case for prophylactic pancreatectomy in lieu of serial screening and shared decision making.

Iskandar ME, Wayne MG, Steele JG, Cooperman AM.

Case Rep Oncol Med. 2014;2014:737183. doi: 10.1155/2014/737183. Epub 2014 Nov 20.

15.

Prevalence of germline mutations in cancer predisposition genes in patients with pancreatic cancer.

Grant RC, Selander I, Connor AA, Selvarajah S, Borgida A, Briollais L, Petersen GM, Lerner-Ellis J, Holter S, Gallinger S.

Gastroenterology. 2015 Mar;148(3):556-64. doi: 10.1053/j.gastro.2014.11.042. Epub 2014 Dec 2.

16.

BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study.

Zhen DB, Rabe KG, Gallinger S, Syngal S, Schwartz AG, Goggins MG, Hruban RH, Cote ML, McWilliams RR, Roberts NJ, Cannon-Albright LA, Li D, Moyes K, Wenstrup RJ, Hartman AR, Seminara D, Klein AP, Petersen GM.

Genet Med. 2015 Jul;17(7):569-77. doi: 10.1038/gim.2014.153. Epub 2014 Nov 20.

17.

Familial and sporadic pancreatic cancer share the same molecular pathogenesis.

Norris AL, Roberts NJ, Jones S, Wheelan SJ, Papadopoulos N, Vogelstein B, Kinzler KW, Hruban RH, Klein AP, Eshleman JR.

Fam Cancer. 2015 Mar;14(1):95-103. doi: 10.1007/s10689-014-9755-y.

18.

Therapeutic options for the management of pancreatic cancer.

Rossi ML, Rehman AA, Gondi CS.

World J Gastroenterol. 2014 Aug 28;20(32):11142-59. doi: 10.3748/wjg.v20.i32.11142. Review.

19.

Association between allergies and risk of pancreatic cancer.

Cotterchio M, Lowcock E, Hudson TJ, Greenwood C, Gallinger S.

Cancer Epidemiol Biomarkers Prev. 2014 Mar;23(3):469-80. doi: 10.1158/1055-9965.EPI-13-0965. Epub 2014 Feb 19.

20.

Risk factors and therapeutic targets in pancreatic cancer.

Wörmann SM, Algül H.

Front Oncol. 2013 Nov 18;3:282. doi: 10.3389/fonc.2013.00282. Review.

Supplemental Content

Support Center